Avid Bioservices Inc (CDMO)

[skweze]

Cheap is a relative term, but with the BOD controlled by investment bankers, it certainly possible, and perhaps even predictable, that their cash out number is lower than the expectation of many longs. Having said that, I imagine that ROI vs free cash is a topic subject to vigorous debate and highly subject to individual investment objectives. I think the biggest concern in a MEDX like scenario is that nascent intellectual property is given away with the developed product. All imo.

A cheap buyout is my main concern regarding PPHM. Me, just like some of you , have also suffered a "cheap" buyout of anothe Co. I was a shareholder. The buyout was terrible for shareholders but I suppose great for the BoD. This is a point that we shareholders should focus on and take the necessary steps for that not to happen. Which ones? I dont know